[andrekandre]

maybe i am not reading it correctly, but from the abstract it says:

   Our study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: -69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine (54.6%, 95% CI: 30.4 to 70.4%).

and the other study:

   This national investigation is one of the first to show that Omicron is less likely to result in COVID-19 hospitalisation than Delta. It finds the rate of possible reinfection for Omicron is 10 times that of Delta. It also finds that third/booster vaccine doses offer considerable additional protection against symptomatic disease when compared to ≥25 weeks post second vaccine dose with these benefits being seen with all available vaccines.

-----

i cant seem to find any evidence in those two papers about the vaccines making someone more susceptible... maybe i missed something?